Provision that could raise drug costs emerges as key obstacle to NAFTA approval

8-February-2019

Some Democrats in the US, like Canada’s generic drug industry, warn that the new biologics rule would keep drug prices high by requiring citizens to wait longer before they can get their hands on lower-cost similar drugs known as biosimilars.

Post a comment

Who are you?
Your post
  • To create paragraphs, just leave blank lines.